Lynx1 Capital Management LP 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 4:21 pm Purchase | 2026-04-29 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Lynx1 Capital Management LP | 3,013,949 5.100% | 3,013,949 (New Position) | Filing |